Humana Inc vs Remitly Global Inc — how do they compare? Humana Inc trades at $431.03 (market cap $46.49B), while Remitly Global Inc trades at $24.13 (market cap $4.98B). The key difference: Humana Inc is far larger — about 9.3× Remitly Global Inc's market cap, and Humana Inc pays a 0.91% dividend while Remitly Global Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 51 Days and Remitly Global Inc for 53 Days on average.
| HUM | RELY | |
|---|---|---|
Market Cap | $46.49B | $4.98B |
Volume | 2,567,704 | 3,501,150 |
Sector | Health | Technology |
52-Week High | $431.03 | $26.92 |
52-Week Low | $163.67 | $12.20 |
Typical Hold Time | 51 Days | 53 Days |
Enterprise Value | $53.84B | $4.34B |
Dividend Yield | 0.91% | — |
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $387.12, down 2.37% today, with a bullish technical outlook supported by moving averages and strong institutional interest. The company shows steady revenue growth reaching $129.7B in 2025, though net margins have compressed to 0.88%. Recent analyst upgrades and a $460.74 consensus price target suggest upside potential, while Medicare Advantage plan changes and fiduciary scrutiny present near-term headwinds.
The stock offers value with a low P/S ratio of 0.32x and consistent earnings beats, but faces margin pressure and regulatory risks. Institutional accumulation and positive technicals support a constructive outlook, though investors should monitor enrollment trends and cost management execution for sustained growth.
RELY trades at $23.52, up 2.57% today, with strong bullish technical signals from moving averages and a positive earnings trend, having beaten estimates in recent quarters. Revenue grew to $1.64 billion in 2025, with net income turning positive at $67.93 million, and cash flow from operations surged to $325.08 million. Recent news highlights partnerships and institutional interest, supporting the stock's momentum near its 52-week high.
The outlook is positive with a consensus price target of $30.50, reflecting 30% upside, driven by robust revenue growth and expanding margins. Risks include high valuation multiples and competitive pressures in digital payments, but analyst sentiment remains overwhelmingly bullish with 92% buy ratings.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →Remitly Global Inc provides integrated financial services to immigrants, including helping customers send money internationally in a quick, reliable, and more cost-effective manner by leveraging digital channels. It supports cross-border transmissions across the globe. Its revenue is generated on transaction fees charged to customers and foreign exchange spreads between the foreign exchange rate offered to customers and the foreign exchange rate on the company's currency purchases.
Read more on RELY →